SCHEMBL29989315

SCHEMBL29989315

CCOC(=O)c1cnn2ccc(N[C@H](C)c3cccnc3OC)nc12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 3/20 0.48
▸ HPGD P15428 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ AAK1 Q2M2I8 1/20 0.39
▸ NTRK1 P04629 5/20 0.39
▸ NTRK3 Q16288 3/20 0.39
▸ NTRK2 Q16620 3/20 0.39
▸ PDE2A O00408 2/20 0.38
▸ IRAK4 Q9NWZ3 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ TYK2 P29597 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PDE4D Q08499 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23500992 1.00 TGFBR1 (0.48) TGFBR1HPGDALDH1A1LMNAHSD17B10
SCHEMBL23500995 1.00 TGFBR1 (0.48) TGFBR1HPGDALDH1A1LMNAHSD17B10
SCHEMBL23501007 0.89 AAK1 (0.42) TGFBR1AAK1NTRK1NTRK3NTRK2
SCHEMBL23501010 0.89 AAK1 (0.42) TGFBR1AAK1NTRK1NTRK3NTRK2
SCHEMBL18361533 0.86 NTRK1 (0.46) TGFBR1NTRK1NTRK3NTRK2
SCHEMBL18361456 0.84 TGFBR1 (0.49) TGFBR1HPGDALDH1A1LMNAHSD17B10
SCHEMBL23501053 0.83 TGFBR1 (0.46) TGFBR1HPGDALDH1A1LMNAHSD17B10
SCHEMBL23501055 0.83 TGFBR1 (0.46) TGFBR1HPGDALDH1A1LMNAHSD17B10
SCHEMBL30255028 0.83 HPGD (0.38) TGFBR1HPGDALDH1A1LMNAHSD17B10
SCHEMBL18361539 0.79 NTRK1 (0.47) TGFBR1NTRK1NTRK3NTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428433-B2 Fluorine-containing heterocyclic derivatives with macrocyclic structure and use thereof SCINNOHUB PHARMACEUTICAL CO., LTD (CN) 2025-09-30 — — US disclosed
US-20230044722-A1 FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) 2023-02-09 — — US disclosed
EP-4074715-A1 FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF Scinnohub Pharmaceutical Co., Ltd (CN) 2022-10-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428433-B2 Fluorine-containing heterocyclic derivatives with macrocyclic structure and use thereof FRK, BRAF, ERBB3 TGFBR1 2354/4885HPGD 3775/4885ALDH1A1 4290/4885
US-20230044722-A1 FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF FRK, BRAF, ERBB3 TGFBR1 2354/4885HPGD 3775/4885ALDH1A1 4290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback